Literature DB >> 18165775

Is early recurrence of hepatitis C associated with biliary anastomotic stricture after liver transplantation?

Shiro Fujita1, Takahisa Fujikawa, Shugo Mizuno, Alan I Reed, Robin D Kim, Richard J Howard, Roberto J Firpi, David R Nelson, Alan W Hemming.   

Abstract

BACKGROUND: While the main effect of hepatitis C virus (HCV) is hepatitis, HCV is also known to cause a variety of systemic immunologic inflammatory abnormalities. The effect of HCV infection on the biliary tract after liver transplantation (LT) is not well understood. The aim of the current study is to determine if recurrence of hepatitis C affects biliary complications after LT, with special reference to late biliary anastomotic strictures (LBAS).
METHODS: A total of 688 consecutive adult LT recipients with a choledochocholedochostomy without T-tube placement between 1990 and 2005 were reviewed. Biliary anastomotic stricture was confirmed by endoscopic retrograde cholangiopancreatography. LBAS was defined as stricture that occurred 30 days or more after LT. Early HCV recurrence was defined as recurrence within 6 months after LT.
RESULTS: LBAS occurred in 55 patients (8% of total). Patients with HCV infection had a higher occurrence of LBAS than non-HCV patients (11% vs. 5%, P=0.0093). Among HCV patients, those with early HCV recurrence had an exceedingly high rate of LBAS (16%). In multivariate analyses, early recurrence of hepatitis C (P<0.0001), as well as occurrence of hepatic artery thrombosis (P=0.0018) and prolonged cold ischemic time (P=0.034), were independent risk factors affecting LBAS. Among HCV patients, those with LBAS had a significantly higher hepatitis activity index score (3.1 vs. 1.4, P<0.0001) and fibrosis stage (0.9 vs. 0.4, P<0.0001) as compared to patients without LBAS.
CONCLUSION: Patients with early recurrence of HCV have increased occurrence of late biliary anastomotic stricture after liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165775     DOI: 10.1097/01.tp.0000295983.55088.96

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

Review 1.  Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

Authors:  Francesco Vasuri; Deborah Malvi; Elisa Gruppioni; Walter F Grigioni; Antonia D'Errico-Grigioni
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.

Authors:  Norah A Terrault; R Todd Stravitz; Anna S F Lok; Greg T Everson; Robert S Brown; Laura M Kulik; Kim M Olthoff; Sammy Saab; Ovedele Adeyi; Curtis K Argo; Jay E Everhart; Del R Rodrigo
Journal:  Hepatology       Date:  2014-03-01       Impact factor: 17.425

Review 3.  Endoscopic management of biliary complications after liver transplantation: An evidence-based review.

Authors:  Carlos Macías-Gómez; Jean-Marc Dumonceau
Journal:  World J Gastrointest Endosc       Date:  2015-06-10

4.  Intraoperative cryoprecipitate transfusion and its association with the incidence of biliary complications after liver transplantation--a retrospective cohort study.

Authors:  Shuang Liu; Junwei Fan; Xiaoliang Wang; Zijun Gong; Shuyun Wang; Li Huang; Tonghai Xing; Tao Li; Zhihai Peng; Xing Sun
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.